(August 9, 2017) The International Journal of Cancer recently published an article on preliminary findings for two factors that influence one’s risk of ovarian cancer, namely the age at which a woman gives birth and the age at which she starts using oral contraceptives. The authors, including Celeste Leigh Pearce, PhD of OCRFA’s Scientific Advisory Committee, studied data on almost 4,000 women, and found that women who had their first child after 35 had a 47% lower risk of developing ovarian cancer than women who had their first child before 25 years of age. Additionally, for every 5 years a woman waited to give birth for the first time, the risk was reduced by thirteen percent. They also found that women using oral contraceptives before the age of 35 had greater protection from ovarian cancer than those who started at a later age. Current and previous data support the fact that the effects seen from later births last for at least 30 years after the last time a woman gave birth. However, the effects seen from earlier use of oral contraceptives need further study as not all data comes to the same conclusion.
Related Topics
The Overview: June 2026
Nearly 500 people have already registered for OCRA’s International Gynecologic Cancer Conference®—the largest conference dedicated to the gynecologic cancer community—taking place on September 16–17. The conference is free, online, and open to all, and will include programming for ovarian, endometrial, cervical, and rare gynecologic cancers. For the first time, each of these diseases will have a dedicated Ask the Experts session. Learn … Continued
Inside the Think Tank: Stopping Ovarian Cancer Before it Starts
On June 1–2, the Ovarian Cancer Observatory—part of OCRA’s broader investment in research initiatives—convened its first in-person Forum in Vancouver. Roughly 50 of the field’s brightest clinicians, pathologists, and epidemiologists gathered for what became, in essence, a two-day think tank on preventing ovarian cancer. The Observatory is funded through a grant from OCRA and was … Continued
OCRA-Funded ROCCA Platform Launches to Accelerate Rare Ovarian Cancer Research
OCRA is proud to announce the launch of the Rare Ovarian Cancer Collaborative Analytics (ROCCA) Platform, an international federated data network funded by OCRA to connect researchers globally and accelerate breakthroughs in rare ovarian cancer research. A collaborative approach to research for rare ovarian cancer ROCCA is launching with two foundational projects: one in mucinous … Continued